[Current epilepsy treatment in adults].
The prevalence of epilepsy is about 1%. Only two thirds of these patients respond satisfactorily to an antiepileptic drug (AED) treatment. New AED did not clearly improve this overall efficacy, but often show a better tolerability as compared to old AED. This may allow a more targeted choice, especially in some delicate clinical situations, such as for the treatment of women in childbearing age, or patients receiving other drugs with possible pharmacokinetic interactions. Invasive approaches should be considered early in the course of treatment-resistant epilepsy, and may offer a complete seizure remission in selected cases. On the background of recent acquisitions from the literature, the pros and cons of different treatment options are presented. This is followed by the discussion of some clinical relevant situations.
Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. arossetti@partners.org
A O
AO
Rossetti
J-G
JG
Villemure
M
M
Seeck
O
O
Prilipko
P-A
PA
Despland
P
P
Jallon
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D004827:Epilepsy / Q000628:therapy*; D006801:Humans; D019635:Neurosurgical Procedures
D000927:Anticonvulsants